Actualités et Activités de CalciMedica
Dirigeants
Voir l'organigramme avec ses 16 principaux dirigeants
Biographies les plus recherchées chez CalciMedica
- Rachel Leheny, Director and Chief Executive Officer
- Evgeny Zaytsev, Director
- Robert Wilson, Chairman of the Board
Changements de dirigeants chez CalciMedica
- Fred Middleton, Director, a quitté l'entreprise (publié le 8 juillet 2026).
- Evgeny Zaytsev, a rejoint l'entreprise comme Director (publié le 8 juillet 2026).
- Fred Guerard, Director, a quitté l'entreprise (publié le 8 juillet 2026).
Créer une alerte
pour suivre les mouvements de dirigeants chez CalciMedica.
Biotechnologie
CalciMedica a 2 429 concurrents dont Lonza (Suisse), Vertex Pharmaceuticals (Etats—Unis) et Eurofins (Luxembourg).
Actualités en fusion/acquisition en Biotechnologie.
- Tempus has announced the acquisition of Personalis (publié le 20 juillet 2026).
- Eli Lilly has announced the acquisition of AtaiBeckley (publié le 17 juillet 2026).
- GSK a acquis Nuvalent (publié le 17 juillet 2026).
Contacts en Biotechnologie
Actualités
Derniers communiqués de presse par CalciMedica
- CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data | CalciMedica, Inc.
- CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates | CalciMedica, Inc.
- CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program | CalciMedica, Inc.
- CalciMedica Reports 2025 Financial Results and Provides Clinical Updates | CalciMedica, Inc.
- CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation | CalciMedica, Inc.
- CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates | CalciMedica, Inc.
- CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension | CalciMedica, Inc.
- CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 | CalciMedica, Inc.
- CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ | CalciMedica, Inc.
- CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference | CalciMedica, Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de CalciMedica
- CalciMedica sur Wikipédia, Google News & Yahoo Finance en 1-click
- CalciMedica sur LinkedIn, X (Twitter) & YouTube en 1-click
